The phosphodiesterase inhibitor pentoxifylline reduces early side effects of interferon-β1b treatment in patients with multiple sclerosis

Neurology

Volumn 47, Issue 2, 1996, Pages 604-

  Rieckmann, P ^a   Weber, F ^a   Gunther, A ^a   Poser, S ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTERFERON; GAMMA INTERFERON; PHOSPHODIESTERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOSE RESPONSE; ENZYME INHIBITION; FEVER; HUMAN; LYMPHOCYTOPENIA; MULTIPLE SCLEROSIS; MYALGIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029834973     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.2.604     Document Type: Article

References (0)